LEN, which is mainly catalyzed by CYP3A, is used to treat various cancers, including hepatocellular carcinoma, thyroid cancer, endometrial cancer, and renal cell carcinoma.1, 2, 3, 4, 5, 21. This evidence concerns the gene CYP3A4 and thyroid gland carcinoma.